PNC Financial Services Group
STOK icon

PNC Financial Services Group’s Stoke Therapeutics STOK Stock Holding History

PNC Financial Services Group’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.43K Hold
44
– – ﹤0.01% 4673
2025
Q4 		$1.4K Hold
44
– – ﹤0.01% 4615
2025
Q3 		$1.03K Hold
44
– – ﹤0.01% 4670
2025
Q2 		$499 Hold
44
– – ﹤0.01% 4686
2025
Q1 		$293 Buy
44
+34
+340% +$317 ﹤0.01% 4731
2024
Q4 		$110 Hold
10
– – ﹤0.01% 4704
2024
Q3 		$123 Hold
10
– – ﹤0.01% 4713
2024
Q2 		$135 Buy
10
+5
+100% +$68 ﹤0.01% 4704
2024
Q1 		$68 Hold
5
– – ﹤0.01% 4657
2023
Q4 		$26 Buy
+5
New +$21 ﹤0.01% 4593

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PNC Financial Services Group's STOK Position: Q1 2026 in Review

PNC Financial Services Group held its Stoke Therapeutics (STOK) position steady in Q1 2026 at 44 shares worth $1.43K. The position accounts for ﹤0.01% of the portfolio, ranked #4673.

PNC Financial Services Group first reported a position in STOK in Q4 2023 and has held it in 10 quarters since. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

  • PNC Financial Services Group held 44 shares of Stoke Therapeutics worth $1.43K as of Q1 2026.
  • PNC Financial Services Group left its Stoke Therapeutics share count unchanged in Q1 2026.
  • Stoke Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4673 holding.
  • PNC Financial Services Group first reported a position in Stoke Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • 196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.